Colistimethate (Colistin) Suppliers & Bulk Manufacturers
Available Forms: Intravenous (IV) Injection
Available Strengths: 150 mg Colistin base activity (equivalent to 1 million IU)
Reference Brands: Coly-Mycin M(US); Colomycin(EU)
Category:
Critical Care
Colistimethate (Colistin) is a critical antibiotic for treating drug-resistant Gram-negative infections. Supplied as 150 mg (1 million IU) IV vials or nebulized solutions, brands include Coly-Mycin M and Colomycin. Pharma B2B platforms offer reliable bulk sourcing for hospitals and ICUs combating antimicrobial resistance.
Colistimethate (Colistin) is available in Intravenous (IV) Injection
and strengths such as 150 mg Colistin base activity (equivalent to 1 million IU).
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Colistimethate (Colistin) is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Colistimethate (Colistin) can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Colistimethate sodium (Colistin) is a last-resort polymyxin antibiotic used to treat multidrug-resistant Gram-negative infections, particularly in ICU settings. It is primarily available as a lyophilized powder for IV injection in 1 million IU or 150 mg vials, and also in nebulized form for inhalation therapy. In the US, it is sold as Coly-Mycin M by Pfizer and through generics from Xellia and Hikma. In the EU, it is branded as Colomycin, and available via Sandoz, Hikma, and other suppliers. Pharma B2B platforms ensure dependable sourcing of Colistin for hospitals managing critical care and antimicrobial resistance cases.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing